Ethanolamine kinase

From WikiMD's Medical Encyclopedia

Revision as of 23:14, 3 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Ethanolamine kinase (EK) is an enzyme that catalyzes the phosphorylation of ethanolamine, a primary amine and a primary alcohol. This reaction is the first step in the CDP-ethanolamine pathway, which is the primary method for the synthesis of phosphatidylethanolamine in mammalian cells.

Function

Ethanolamine kinase catalyzes the ATP-dependent phosphorylation of ethanolamine, producing phosphoethanolamine and ADP. This is the first step in the CDP-ethanolamine pathway, which ultimately leads to the production of phosphatidylethanolamine. Phosphatidylethanolamine is a major component of the inner leaflet of the lipid bilayer in mammalian cells and is involved in many cellular processes, including protein folding and membrane fusion.

Structure

The structure of ethanolamine kinase is not fully understood. However, it is known to be a monomer and is believed to have a two-domain structure. The larger domain is thought to bind ATP and ethanolamine, while the smaller domain is believed to be involved in the transfer of the phosphate group.

Clinical significance

Alterations in the activity of ethanolamine kinase have been implicated in several diseases. For example, increased activity of this enzyme has been observed in cancer cells, suggesting that it may play a role in tumor growth and progression. Additionally, mutations in the gene encoding ethanolamine kinase have been associated with neurological disorders.

See also

References

Stub icon
   This article is a enzyme-related stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.